Literature DB >> 25336296

[Digital ulcers in systemic scleroderma].

D Belz1, N Hunzelmann, P Moinzadeh.   

Abstract

Digital ulcers (DU's) are one of the main symptoms of systemic scleroderma and occur in approximately 60% of all scleroderma patients. Due to possible complications such as infections, gangrene or amputation, they require regular medical attention and a good wound treatment by doctors and nursing staff. A definition of DU's has not yet been established. In 2009 the European League Against Rheumatism (EULAR) published guidelines for the treatment of DU's. An improvement of the healing of active ulcers has been described with Iloprost. Bosentan significantly reduced the frequency of occurrence of new DU's. In some small studies PDE-5 inhibitors appear helpful. Further studies with other therapeutic approaches will follow in the next few years.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25336296     DOI: 10.1007/s00105-014-3528-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  30 in total

Review 1.  Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients.

Authors:  Clodoveo Ferri; Gabriele Valentini; Franco Cozzi; Marco Sebastiani; Claudio Michelassi; Giovanni La Montagna; Arianna Bullo; Massimiliano Cazzato; Enrico Tirri; Franca Storino; Dilia Giuggioli; Giovanna Cuomo; Mara Rosada; Stefano Bombardieri; Silvano Todesco; Giuseppe Tirri
Journal:  Medicine (Baltimore)       Date:  2002-03       Impact factor: 1.889

2.  Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions.

Authors:  Vanessa Smith; Filip De Keyser; Carmen Pizzorni; Jens T Van Praet; Saskia Decuman; Alberto Sulli; Ellen Deschepper; Maurizio Cutolo
Journal:  Ann Rheum Dis       Date:  2010-10-21       Impact factor: 19.103

Review 3.  Surgery of the hand in patients with systemic sclerosis: outcomes and considerations.

Authors:  Earl R Bogoch; Dagmar K Gross
Journal:  J Rheumatol       Date:  2005-04       Impact factor: 4.666

4.  Peripheral vasculopathy in patients with systemic sclerosis: difference in limited and diffuse subset of disease.

Authors:  Predrag Ostojić; Nemanja Damjanov; Slavica Pavlov-Dolijanovic; Goran Radunović
Journal:  Clin Hemorheol Microcirc       Date:  2004       Impact factor: 2.375

5.  EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Authors:  O Kowal-Bielecka; R Landewé; J Avouac; S Chwiesko; I Miniati; L Czirjak; P Clements; C Denton; D Farge; K Fligelstone; I Földvari; D E Furst; U Müller-Ladner; J Seibold; R M Silver; K Takehara; B Garay Toth; A Tyndall; G Valentini; F van den Hoogen; F Wigley; F Zulian; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2009-01-15       Impact factor: 19.103

6.  Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors.

Authors:  C Sunderkötter; I Herrgott; C Brückner; P Moinzadeh; C Pfeiffer; J Gerss; N Hunzelmann; M Böhm; T Krieg; U Müller-Ladner; E Genth; E Schulze-Lohoff; M Meurer; I Melchers; G Riemekasten
Journal:  Br J Dermatol       Date:  2009-01-13       Impact factor: 9.302

7.  Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study.

Authors:  F M Wigley; R A Wise; J R Seibold; D A McCloskey; G Kujala; T A Medsger; V D Steen; J Varga; S Jimenez; M Mayes; P J Clements; S R Weiner; J Porter; M Ellman; C Wise; L D Kaufman; J Williams; W Dole
Journal:  Ann Intern Med       Date:  1994-02-01       Impact factor: 25.391

8.  Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.

Authors:  Anna Abou-Raya; Suzan Abou-Raya; Madihah Helmii
Journal:  J Rheumatol       Date:  2008-08-15       Impact factor: 4.666

Review 9.  [Iloprost therapy in systemic sclerosis].

Authors:  G Bali; E Aberer
Journal:  Hautarzt       Date:  2003-09       Impact factor: 0.751

Review 10.  Clinical Impact Upon Wound Healing and Inflammation in Moist, Wet, and Dry Environments.

Authors:  Johan P E Junker; Rami A Kamel; E J Caterson; Elof Eriksson
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-09       Impact factor: 4.730

View more
  2 in total

Review 1.  [Systemic sclerosis. Current classification and diagnosis of organ involvement].

Authors:  O D Persa; P Moinzadeh; N Hunzelmann
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

Review 2.  [Current treatment of systemic scleroderma].

Authors:  Nicolas Hunzelmann
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.